DUBLIN–(BUSINESS WIRE)–The “Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) – Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering. Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) pipeline Target … Continue reading
Cet article Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) – Pipeline Review, H1 2018 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.